A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages - PubMed (original) (raw)
. 1992 Nov 25;267(33):23664-73.
Affiliations
- PMID: 1331096
Free article
A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages
C el-Moatassim et al. J Biol Chem. 1992.
Free article
Abstract
Macrophages express two distinct types of nucleotide (P2 purinergic) receptors for extracellular ATP: one type induces a Ca(2+)-mobilizing response via the activation of phosphatidylinositol-phospholipase C (PI-PLC) while the second type induces the rapid formation of nonselective pores which are permeated by ions and small (< 1 kDa) organic molecules. We have confirmed the presence of these two ATP receptor types in the BAC1.2F5 murine macrophage cell line and have identified 3'-O-(4-benzoyl)benzoyl-ATP (BzATP) as a selective and potent agonist for the so-called P2z or pore-forming ATP receptor type. Several lines of evidence indicated that occupation of these P2z receptors is also accompanied by a rapid and large increase in the activity of a phosphatidylcholine-selective phospholipase D (PLD) effector enzyme. In cells metabolically labeled with [3H]oleic acid or [3H]glycerol and stimulated in the presence of ethanol, ATP and BzATP induced a severalfold increase in the rate and extent of [3H]phosphatidylethanol (PEt) accumulation. These responses were stimulated only by ATP, BzATP, and ATP gamma S (adenosine 5'-O-(3-thiotriphosphate) with the rank order of potency: BzATP >> ATP > ATP gamma A; there was no response to other adenine nucleotides or to non-adenine nucleotides. Significantly, the ability of P2z receptor agonists to stimulate this PLD activity was not dependent on the presence of extracellular [Ca2+] or elevation of cytosolic [Ca2+]. The inability of ionomycin, gramicidin, digitonin, UTP, platelet-activating factor, or phorbol ester to quantitatively mimic these nucleotide effects suggested that activation of this PLD by P2z receptor agonists was not a secondary response due to: 1) enhanced Ca2+ influx; 2) membrane depolarization; 3) nonselective permeabilization of the plasma membrane; 4) stimulation of Ca(2+)-mobilizing ATP receptors; 5) stimulation of a primary PI-PLC pathway; or 6) activation of protein kinase C. These findings suggest that activation of a novel PLD-based signaling pathway may play an important role in the modulation of macrophage function by pore-forming P2z receptors for extracellular ATP.
Similar articles
- Expression of the pore-forming P2Z purinoreceptor in Xenopus oocytes injected with poly(A)+ RNA from murine macrophages.
Nuttle LC, el-Moatassim C, Dubyak GR. Nuttle LC, et al. Mol Pharmacol. 1993 Jul;44(1):93-101. Mol Pharmacol. 1993. PMID: 7688070 - Transduction mechanisms of P2Z purinoceptors.
Wiley JS, Chen JR, Snook MS, Gargett CE, Jamieson GP. Wiley JS, et al. Ciba Found Symp. 1996;198:149-60; discussion 160-5. doi: 10.1002/9780470514900.ch9. Ciba Found Symp. 1996. PMID: 8879824 Review. - Formation of second messengers in response to activation of ion channels in excitable cells.
Gusovsky F, Daly JW. Gusovsky F, et al. Cell Mol Neurobiol. 1988 Jun;8(2):157-69. doi: 10.1007/BF00711242. Cell Mol Neurobiol. 1988. PMID: 2457443 Review.
Cited by
- ATP can stimulate exocytosis in rat brown adipocytes without apparent increases in cytosolic Ca2+ or G protein activation.
Lee SC, Pappone PA. Lee SC, et al. Biophys J. 1999 Apr;76(4):2297-306. doi: 10.1016/S0006-3495(99)77385-6. Biophys J. 1999. PMID: 10096924 Free PMC article. - The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP.
Wiley JS, Chen JR, Snook MB, Jamieson GP. Wiley JS, et al. Br J Pharmacol. 1994 Jul;112(3):946-50. doi: 10.1111/j.1476-5381.1994.tb13172.x. Br J Pharmacol. 1994. PMID: 7921625 Free PMC article. - Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy.
Fyrstenberg Laursen M, Kofod-Olsen E, Agger R. Fyrstenberg Laursen M, et al. Cancer Immunol Immunother. 2019 Nov;68(11):1875-1880. doi: 10.1007/s00262-019-02400-1. Epub 2019 Sep 26. Cancer Immunol Immunother. 2019. PMID: 31559451 Free PMC article. Review. - Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue.
Jarvis MF, Wismer CT, Schweitzer E, Yu H, van Biesen T, Lynch KJ, Burgard EC, Kowaluk EA. Jarvis MF, et al. Br J Pharmacol. 2001 Jan;132(1):259-69. doi: 10.1038/sj.bjp.0703793. Br J Pharmacol. 2001. PMID: 11156585 Free PMC article. - Bradykinin stimulates phospholipase D in PC12 cells by a mechanism which is independent of increases in intracellular Ca2+.
Horwitz J, Passarello B, Corso M. Horwitz J, et al. Neurochem Res. 1995 Sep;20(9):1041-8. doi: 10.1007/BF00995558. Neurochem Res. 1995. PMID: 8570008
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous